Research

New APC research helps us to better understand Long COVID

New study from APC Microbiome, finds biomarkers of immune system activation are linked with impaired metabolism in Long COVID patients

New APC research helps us to better understand Long COVID
Free Pic No Repro Fee Feb 2022 New APC research that helps us to better understand Long COVID was published this week in the international scientific journal Allergy. The research was led by Prof Liam O’Mahony Principal Investigator at APC Microbiome Ireland SFI Research Centre & Prof of Immunology University College Cork and first authored Dr Corinna Sadlier, Consultant in Infectious Diseases at Cork University Hospita both pictured here with Director of APC Microbiome Ireland Prof Paul Ross. Images by Gerard McCarthy 087 8537228 For more info contact Tina Darb TDarb@ucc.ie

A new Long COVID study from APC Microbiome Ireland, a world-leading SFI Research Centre based at University College Cork (UCC), finds that biomarkers of immune system activation are linked with impaired metabolism in Long COVID patients. It helps scientists understand the pathobiology of SARS-CoV-2 infection and associated long-term consequences.

The research led by Prof. Liam O’Mahony and first authored by Dr. Corinna Sadlier, published this week in the international scientific journal “Allergy”. It shows that the levels of multiple biomarkers are altered in serum from patients with Long COVID. This is even nine months after the initial infection with SARS-CoV-2. Over 1,000 molecules were measured in patient serum. A subset of these molecules were shown to be at different levels in patients compared to healthy volunteers. These differences indicate an ongoing activation of the immune system, which were coupled with differences in molecules generated during metabolism. These differences in metabolism (e.g. decreased serotonin levels) give us some hints at what might be underpinning long term symptoms. These symptoms can be fatigue and also brain fog. Overall the study findings identify novel mechanistic and potential diagnostic markers as well as potential therapeutic targets in Long COVID patients.

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free